JOURNAL ARTICLE

Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID‐19 Vaccination in Heart Transplant Recipients.

  • Published In: Clinical Transplantation, 2025, v. 39, n. 5. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Arcani, Robin; Ambrosi, Pierre 3 of 3

Abstract

We previously reported a high level of seroconversion 1 year after COVID‐19 vaccination in heart transplant recipients when vaccination was performed several years after transplantation. The aim of this study was to measure the seroconversion rate late after vaccination, in the absence of a new vaccine injection. We included 37 patients vaccinated in 2021. We measured immunoglobulin response using TrimericS Diasorin assay at the last visit between October 2024 and February 2025. We found a seroconversion rate of 95%, 3.2 ± 0.13 years after last COVID‐19 vaccination in the absence of new vaccine injection. Most of these patients (73%) had a proven COVID‐19 infection since vaccination. Interestingly, none of these patients had a severe form of COVID‐19. Thus, vaccination, followed by minor COVID‐19 infections, effectively prevented severe forms. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Clinical Transplantation. 2025/05, Vol. 39, Issue 5, p1
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2025
  • ISSN:0902-0063
  • DOI:10.1111/ctr.70190
  • Accession Number:185414547
  • Copyright Statement:Copyright of Clinical Transplantation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.